Human medicines
Oncaspar solution for injection
The company responsible for distribution, sigma-tau ArzneimittelGmbH, 40212 Düsseldorf, Germany, informed its supplied customers on November 15, 2013,…
Oncaspar
Due to a possible quality defect, the companies Sigma-Tau Arzneimittel GmbH and Sigma-Tau Rare Diseases S.A. have decided to recall the above…
Jext solution for injection
Due to a technical defect, there is a possibility in a small number of Jext epinephrine auto-injectors that the epinephrine is not correctly applied…
Jext
In a small number (0.04% corresponds to 4/10,000) of Jext® pre-filled pens, the adrenaline injection may not be carried out in case of need due to a…
NovoMix
Due to a manufacturing problem during the filling of the cartridges, individual products of the above mentioned batches of "NovoMix® 30 FLexPen®" may…
Lovenox Pen
The marketing authorization holder has informed its supplied customers in a letter dated 11.10.2013 that complaints have arisen describing the…
Tardocillin
On October 8, 2013, the marketing authorization holder informed its customers that injection vials may have an externally invisible defect under the…
Denosumab (investigational product)
During a routine quality check, a small number of prefilled syringes were found to contain particles consisting mainly of cellulose fibers. The…
Dancor
The marketing authorization holder has informed its supplied customers in a letter dated 13.09.2013 that investigations have shown that the optimal…
Soliris
The marketing authorization holder informed its supplied customers in a letter dated August 22, 2013, that visible particles were detected in some…